Marketing of pharmaceutical products, generic medicines, and related formulations in India and globally.
Annual revenue $352,396 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Indolands Pharma

Indolands Pharma is a company. Indolands Pharma offers products and services including Generic Medicines and Finished Dosage Forms.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $352.4 K (USD)
    5.98
    as on Mar 31, 2021
  • Net Profit
    $841.28 (USD)
    106.73
    as on Mar 31, 2021
  • EBITDA
    -$1.64 K (USD)
    87.98
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Indolands Pharma

Indolands Pharma offers a comprehensive portfolio of products and services, including Generic Medicines and Finished Dosage Forms.

Product name locked
Category locked
Primary

Generic medicines are marketed for various therapeutic segments including anti-infectives and nutritional deficiencies.

Product name locked
Category locked
Locked

Finished dosage forms such as tablets and syrups are provided across categories like dermatology and pain management.

Funding Insights of Indolands Pharma

Premium access

Detailed funding history for Indolands Pharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Indolands Pharma

Investments
Premium access

Investment portfolio details for Indolands Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Indolands Pharma

Premium access

Detailed financials for Indolands Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Indolands Pharma Comparisons

Indolands Pharma Primary company
Description
Marketing of pharmaceutical products, generic medicines, and...
Location
-
Founded Year
-
Annual Revenue
$352.4 K (USD)
Net Profit
$841.28 (USD)
EBITDA
-$1.64 K (USD)
Employees
Not available
Premium access

Peer comparison for Indolands Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Indolands Pharma

Premium access

Detailed competitors of Indolands Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Indolands Pharma

Premium access

Complete news archive for Indolands Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indolands Pharma

Annual revenue of Indolands Pharma is $352.4K as on Mar 31, 2021.

Indolands Pharma is identified as a privately held Indian pharmaceutical company that markets a broad range of finished dosage forms, which are manufactured at facilities adhering to WHO-GMP standards. These products are commercialized as affordable generic medicines across key therapeutic segments, including dermatology, anti-infectives, and cardiovascular care. A commitment to quality is evident through the use of state-of-the-art equipment and a zero-defect quality management system. The company is noted for its export-oriented approach, with products distributed in multiple countries, aiming to enhance global access to health solutions. Efforts are directed towards creating value-added healthcare options while maintaining affordability.

Indolands Pharma offers Generic Medicines and Finished Dosage Forms.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available